Ignite Creation Date:
2025-12-24 @ 1:15 PM
Ignite Modification Date:
2026-02-26 @ 6:53 AM
Study NCT ID:
NCT02822495
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2023-06-15
First Post:
2016-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Sponsor:
Atara Biotherapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ATA129-EAP-901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None